We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Scheduled to Meet With FDA to Discuss Plan B
Barr Scheduled to Meet With FDA to Discuss Plan B
September 20, 2005
Barr Pharmaceuticals said Sept. 9 it will meet with the FDA in the next few weeks to discuss its controversial oral contraceptive
Plan B, which remains in limbo after the FDA delayed its decision whether to allow the drug to be sold OTC.